Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The iPSC perspective on schizophrenia
Noora Räsänen, Jari Tiihonen, Marja Koskuvi, et al.
Trends in Neurosciences (2021) Vol. 45, Iss. 1, pp. 8-26
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 59
Astrocytes as master modulators of neural networks: Synaptic functions and disease‐associated dysfunction of astrocytes
Jeffrey A. Stogsdill, Corey C. Harwell, Steven A. Goldman
Annals of the New York Academy of Sciences (2023) Vol. 1525, Iss. 1, pp. 41-60
Open Access | Times Cited: 22
Monozygotic twins discordant for schizophrenia differ in maturation and synaptic transmission
Shani Stern, Lei Zhang, Meiyan Wang, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 10, pp. 3208-3222
Open Access | Times Cited: 11
The Genesis of Schizophrenia: An Origin Story
Rebecca Birnbaum, Daniel R. Weinberger
American Journal of Psychiatry (2024) Vol. 181, Iss. 6, pp. 482-492
Closed Access | Times Cited: 8
The role of insulin/IGF1 signalling in neurodevelopmental and neuropsychiatric disorders – Evidence from human neuronal cell models
János Réthelyi, Katalin Vincze, Dorothea Schall, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 153, pp. 105330-105330
Open Access | Times Cited: 19
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models
Andrea Perrottelli, Francesco Flavio Marzocchi, Edoardo Caporusso, et al.
Journal of Psychiatry and Neuroscience (2024) Vol. 49, Iss. 2, pp. E109-E125
Open Access | Times Cited: 5
Model Building for the Study of Schizophrenia
Joshua A. Gordon
Oxford University Press eBooks (2025), pp. 175-184
Closed Access
Neurobiological perturbations in bipolar disorder compared to schizophrenia – evidence from cell cultures and brain organoids
Ibrahim A. Akkouh, Jordi Requena Osete, Attila Szabó, et al.
Biological Psychiatry (2025)
Open Access
Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study
Cristine Marie Yde Ohki, Natalie Monet Walter, Audrey Bender, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 3, pp. 243-252
Open Access | Times Cited: 12
Somatic mutations alter the differentiation outcomes of iPSC-derived neurons
Pau Puigdevall, Julie Jerber, Petr Danecek, et al.
Cell Genomics (2023) Vol. 3, Iss. 4, pp. 100280-100280
Open Access | Times Cited: 12
Neuroimaging and multiomics reveal cross-scale circuit abnormalities in schizophrenia
Meng Wang, Hao Yan, Xiaohan Tian, et al.
Nature Mental Health (2023) Vol. 1, Iss. 9, pp. 633-654
Closed Access | Times Cited: 11
Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview
Ashwani Choudhary, David Peles, Ritu Nayak, et al.
Schizophrenia Research (2022)
Open Access | Times Cited: 17
Recapitulation of Perturbed Striatal Gene Expression Dynamics of Donors’ Brains With Ventral Forebrain Organoids Derived From the Same Individuals With Schizophrenia
Tomoyo Sawada, André R. Barbosa, Bruno Henrique Silva Araújo, et al.
American Journal of Psychiatry (2023) Vol. 181, Iss. 6, pp. 493-511
Closed Access | Times Cited: 10
Morphological and transcriptomic analyses of stem cell-derived cortical neurons reveal mechanisms underlying synaptic dysfunction in schizophrenia
Annie Kathuria, Kara Lopez-Lengowski, Bradley Watmuff, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Probing the biological consequences of a previously undescribed de novo mutation of ZMYND11 in a schizophrenia patient by CRISPR genome editing and induced pluripotent stem cell based in vitro disease-modeling
Csongor Tordai, Edit Hathy, Hella Gyergyák, et al.
Schizophrenia Research (2024)
Open Access | Times Cited: 2
Copy Number Variations and Schizophrenia
Kamila Szecówka, Błażej Misiak, Izabela Łaczmańska, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 4, pp. 1854-1864
Open Access | Times Cited: 12
Cultured Mesenchymal Cells from Nasal Turbinate as a Cellular Model of the Neurodevelopmental Component of Schizophrenia Etiology
Victoria Sook Keng Tung, Fasil Mathews, Marina Boruk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15339-15339
Open Access | Times Cited: 6
Schizophrenia is associated with altered DNA methylation variance
Dylan J. Kiltschewskij, William R. Reay, Murray J. Cairns
Molecular Psychiatry (2024)
Open Access | Times Cited: 1
Current progress in understanding Schizophrenia using genomics and pluripotent stem cells: A Meta-analytical overview
Ashwani Choudhary, Ritu Nayak, David Peles, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 7
Disrupted mossy fiber connections from defective embryonic neurogenesis contribute to SOX11-associated schizophrenia
Xianmixinuer Abulaiti, Ai‐Fang Wang, Han Zhang, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Closed Access | Times Cited: 6
Shedding light on latent pathogenesis and pathophysiology of mental disorders: The potential of iPS cell technology
Yuko Arioka, Hiroki Okumura, Hideya Sakaguchi, et al.
Psychiatry and Clinical Neurosciences (2023) Vol. 77, Iss. 6, pp. 308-314
Open Access | Times Cited: 3
Effects of Medicinal Plants and Phytochemicals on Schizophrenia
Nithya Rani Raju, S. Rashmitha, Shekamoori Pavithra -, et al.
(2023), pp. 81-136
Closed Access | Times Cited: 3
Lower levels of soluble β-amyloid precursor protein, but not β-amyloid, in the frontal cortex in schizophrenia
Brian Dean, James A. Duce, Qiao‐Xin Li, et al.
Psychiatry Research (2023) Vol. 331, pp. 115656-115656
Closed Access | Times Cited: 2
Astrocytes regulate neuronal network burst frequency through NMDA receptors species- and donor-specifically
Noora Räsänen, Jari Tiihonen, Marja Koskuvi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Roles of Ipsc in Advancing Treatments for Neurological Disorders
X Zhang
(2024)
Closed Access
Page 1 - Next Page

Scroll to top